Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 27

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 27
---
 assessment of the Board’s compliance with general corporate governance guidelines and identification of areas in which the Board could improve its performance;

• review shareholder proposals relating to corporate governance and other matters and recommend to the Board the Company’s response to such proposals, as required or advisable;

<div align='center'>13</div>

• consider and recommend to the Board the optimum size, classifications, terms of office of nominees, members and criteria for Board and committee membership;

• recommend the functions of the various committees of the Board, the members of the committees and the chairs of the committees;

• annually conduct a review of the Nominating and Corporate Governance Committee’s performance and annually review the self-evaluations by the other committees of the Board and report to the Board on the conclusions reached with respect to the performance of the other committees of the Board;

• recommend the functions of the various committees or subcommittees of the Board, the members of the committees or subcommittees, and the chairpersons of the committees or subcommittees;

• assist the full Board in determining the independence of its members and nominees at least annually;

• review and make recommendations to the Board concerning the adoption of corporate governance policies and principles for the Company;

• review and recommend to the Board proposed changes to the Company’s Articles and Bylaws, as required or advisable;

• ensure compliance with and routinely review and update the Corporate Governance Guidelines;

• make recommendations to the Board concerning orientation, training, and continuing education of members of the Board and various committees or subcommittees of the Board; and

• annually, at the Nominating Committee’s meeting coincident with the Company’s annual meeting of shareholders, review and determine the compliance of the Company’s directors with the Stock Ownership Guidelines applicable to directors, and report such compliance to the full Board.

The Nominating and Corporate Governance Committee is authorized to delegate responsibilities to subcommittees of the Nominating and Corporate Governance Committee as necessary or appropriate.

#### Ethics and Compliance Committee
The following directors serve on the Ethics and Compliance Committee: William A. Hawkins (Chair), Dr. Cato T. Laurencin, and K. Todd Newton. Each of the Committee members meets the independence requirements of the Nasdaq rules for independence. The Ethics and Compliance Committee held four meetings during the year ended December 31, 2024.

The current charter for the Ethics and Compliance Committee is posted on our website at https://investors.mimedx.com/corporate-governance/highlights. The Ethics and Compliance Committee is required to be